Showing 1,041 - 1,060 results of 47,433 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((wt decrease) OR (we decrease)) ))', query time: 0.68s Refine Results
  1. 1041
  2. 1042

    Image_5_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Extracorporeal life support was used more often in patients treated with CDT, compared to ST (0.5 vs. 0.2%, OR = 2.52, 95% CI 1.88–3.39, p < 0.001). …”
  3. 1043
  4. 1044
  5. 1045
  6. 1046
  7. 1047
  8. 1048

    Treatment outcomes. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  9. 1049

    Quality assessment of included papers. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  10. 1050

    Basic characteristics of the included studies. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  11. 1051
  12. 1052
  13. 1053
  14. 1054
  15. 1055
  16. 1056
  17. 1057
  18. 1058
  19. 1059
  20. 1060

    Image 2_Probiotic Limosilactobacillus reuteri KUB-AC5 decreases urothelial cell invasion and enhances macrophage killing of uropathogenic Escherichia coli in vitro study.tiff by Arishabhas Tantibhadrasapa (13929639)

    Published 2024
    “…However, the antibacterial and immune modulatory effects of AC5 on UPEC have never been explored.</p>Methods<p>Here, we investigated both the direct and indirect effects of AC5 against UPEC isolates (UTI89, CFT073, and clinical MDR UPEC AT31) in vitro. …”